Semaglutide, also known by brand names (Wegovy, Ozempic, Rybelus) is more commonly known as the drug used to treat type II diabetes, however, in more recent studies it has been shown to have health benefits in patients without type II diabetes or cardiovascular issues. This medicine acts as a GLP-1 hormone and works by increasing insulin release, lowering the amount of glucagon released, delaying gastric emptying, and reducing appetite.